Captor Therapeutics ®
News
May 07, 2024
Captor Therapeutics signed the agreement for II phase implementation and financing for Project CT-03
December 14, 2023
Captor Therapeutics has published financial report for Q1-Q3 2023.
December 14, 2023
Captor Therapeutics has submitted phasing applications to NCBiR for projects CT-01 and CT-03
October 13, 2023
Captor Therapeutics has selected ICON as the CRO company to conduct the first phase of clinical trials under the CT-01 project
September 23, 2023
Captor Therapeutics will raise PLN 40 million from share issue for implementation of strategic goals
September 11, 2023
Captor Therapeutics appoints Wedbush as its exclusive strategic financial advisor and establishes relationship with MSQ Ventures in China
September 08, 2023
Captor Therapeutics publishes financial report for the first half of 2023
July 18, 2023
Captor Therapeutics with PLN 52.2 million co-funding from The Medical Research Agency of Poland